MediWound (MDWD) Cash & Equivalents (2013 - 2025)

MediWound's Cash & Equivalents history runs 13 years deep, the most recent figure standing at $4.8 million for Q4 2025.

• On a quarterly basis, Cash & Equivalents fell 85.89% year-over-year to $4.8 million in Q4 2025; TTM through Dec 2025 was $4.8 million, a 85.89% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, down 85.89% from the prior year.
• Cash & Equivalents retreated to $4.8 million in Q4 2025 per MDWD's latest filing, from $59.1 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $59.1 million in Q3 2025 and bottomed at $4.8 million in Q4 2025.
• The 5-year median for Cash & Equivalents is $17.7 million (2021), against an average of $27.3 million.
• Across the five-year window, Cash & Equivalents soared 243.55% in 2023 and plunged 85.89% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $11.0 million in 2021, then surged by 206.85% to $33.9 million in 2022, then tumbled by 64.99% to $11.9 million in 2023, then jumped by 186.58% to $34.0 million in 2024, then plunged by 85.89% to $4.8 million in 2025.
• Per Business Quant, the three latest MDWD Cash & Equivalents figures stand at $4.8 million (Q4 2025), $59.1 million (Q3 2025), and $9.2 million (Q2 2025).